GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules

GSK announced today approval by U.S Food and Drug Administration (F.D.A) for oral HYCAMTIN(R) (topotecan) capsules for the treatment of relapsed small cell lung cancer (SCLC)